Vir Biotechnology, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | — | — | $187.9M |
| FY2018 | $61.6M | $191.6M | $47.6M |
| FY2019 | $88.1M | $512.1M | $109.3M |
| FY2020 | $201.9M | $918.8M | $436.6M |
| FY2021 | $522.4M | $1.95B | $347.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | — | — | $187.9M |
| FY2018 | $61.6M | $191.6M | $47.6M |
| FY2019 | $88.1M | $512.1M | $109.3M |
| FY2020 | $201.9M | $918.8M | $436.6M |
| FY2021 | $522.4M | $1.95B | $347.8M |